Moderating the Negative Impact of Abnormal Screening Mammograms
2 other identifiers
interventional
130
1 country
1
Brief Summary
This project evaluates the impact of CHESS-Mammo by assessing participants' health information competence, psychological distress, and satisfaction with their doctor as measured by previously validated survey questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started May 2010
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 28, 2010
CompletedFirst Posted
Study publicly available on registry
June 29, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMarch 3, 2014
February 1, 2014
3.6 years
June 28, 2010
February 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
This design will allow us to compare the health information competence, psychological distress, and patient satisfaction with their doctor among the two groups.
This is a randomized controlled trial in which half of the participants will receive access to CHESS-Mammo during their diagnostic workup of an abnormal screening mammogram, and the other half will receive basic information in addition to usual care. This design will allow us to compare the health information competence, psychological distress, and patient satisfaction with their doctor among the two groups.
3 weeks
Study Arms (2)
No Intervention: Usual Care
NO INTERVENTIONA group receiving usual care plus 5 reliable websites
Intervention
EXPERIMENTALA group using the Comprehensive Health Enhancement Support System (CHESS.)
Interventions
Half of the participating women will be randomly assigned to usual care and half will be offered a fully CHESS.
Eligibility Criteria
You may qualify if:
- To be eligible for the study, subjects must:
- Be females at least 18 years of age,
- Have had their screening mammogram performed at the UW Breast Center,
- Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),
- Have access to a computer with internet capability.
You may not qualify if:
- Illiterate
- Homeless
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Madisonlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of WI Comprehensive Cancer Center and UW Health Clinics
Madison, Wisconsin, 53716, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2010
First Posted
June 29, 2010
Study Start
May 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
March 3, 2014
Record last verified: 2014-02